Business Description
Aligned Genetics Inc
ISIN : KR7238120000
Compare
Compare
Traded in other countries / regions
238120.Korea IPO Date
2016-11-03Description
Aligned Genetics Inc is engaged in developing automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.96 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | 0.78 | |||||
| Interest Coverage | 13.59 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.7 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.4 | |||||
| 3-Year EBITDA Growth Rate | 36 | |||||
| 3-Year EPS without NRI Growth Rate | 70.8 | |||||
| 3-Year Book Growth Rate | 13.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.15 | |||||
| 9-Day RSI | 62.01 | |||||
| 14-Day RSI | 57.24 | |||||
| 6-1 Month Momentum % | -19.43 | |||||
| 12-1 Month Momentum % | -30.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.95 | |||||
| Quick Ratio | 14.1 | |||||
| Cash Ratio | 12.3 | |||||
| Days Inventory | 383.42 | |||||
| Days Sales Outstanding | 52.56 | |||||
| Days Payable | 14.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 0.2 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.19 | |||||
| Operating Margin % | 17.41 | |||||
| Net Margin % | 16.52 | |||||
| FCF Margin % | 16.11 | |||||
| ROE % | 7.73 | |||||
| ROA % | 6.01 | |||||
| ROIC % | 8.28 | |||||
| 3-Year ROIIC % | 27.37 | |||||
| ROC (Joel Greenblatt) % | 24.4 | |||||
| ROCE % | 8.76 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.52 | |||||
| PE Ratio without NRI | 20.72 | |||||
| Shiller PE Ratio | 101.21 | |||||
| Price-to-Owner-Earnings | 82.81 | |||||
| PS Ratio | 3.06 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 1.39 | |||||
| Price-to-Free-Cash-Flow | 19.02 | |||||
| Price-to-Operating-Cash-Flow | 17.33 | |||||
| EV-to-EBIT | 10.33 | |||||
| EV-to-EBITDA | 8.76 | |||||
| EV-to-Revenue | 2.27 | |||||
| EV-to-FCF | 14.07 | |||||
| Price-to-Projected-FCF | 2.1 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.83 | |||||
| Price-to-Graham-Number | 1.13 | |||||
| Price-to-Net-Current-Asset-Value | 3.37 | |||||
| Price-to-Net-Cash | 6.8 | |||||
| Earnings Yield (Greenblatt) % | 9.68 | |||||
| FCF Yield % | 5.26 | |||||
| Forward Rate of Return (Yacktman) % | 19.62 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aligned Genetics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 14,998.922 | ||
| EPS (TTM) (â‚©) | 172.5 | ||
| Beta | -0.51 | ||
| Volatility % | 17.9 | ||
| 14-Day RSI | 57.24 | ||
| 14-Day ATR (â‚©) | 135.482837 | ||
| 20-Day SMA (â‚©) | 3088.5 | ||
| 12-1 Month Momentum % | -30.39 | ||
| 52-Week Range (â‚©) | 2575 - 4640 | ||
| Shares Outstanding (Mil) | 14.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aligned Genetics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aligned Genetics Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aligned Genetics Inc Frequently Asked Questions
What is Aligned Genetics Inc(XKRX:238120)'s stock price today?
The current price of XKRX:238120 is â‚©3195.00. The 52 week high of XKRX:238120 is â‚©4640.00 and 52 week low is â‚©2575.00.
When is next earnings date of Aligned Genetics Inc(XKRX:238120)?
The next earnings date of Aligned Genetics Inc(XKRX:238120) is .
Does Aligned Genetics Inc(XKRX:238120) pay dividends? If so, how much?
Aligned Genetics Inc(XKRX:238120) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers